Magnusson, M. K., Dahlén, R., Strid, H., Isaksson, S., Simrén, M., Lasson, A., . . . Öhman, L. (2013). CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis. SAGE Publications.

Magnusson, Maria K., Rahil Dahlén, Hans Strid, Stefan Isaksson, Magnus Simrén, Anders Lasson, Antal Bajor, Kjell-Arne Ung, et Lena Öhman. CD25 and TNF Receptor II Reflect Early Primary Response to Infliximab Therapy in Patients With Ulcerative Colitis. SAGE Publications, 2013.

Magnusson, Maria K., et al. CD25 and TNF Receptor II Reflect Early Primary Response to Infliximab Therapy in Patients With Ulcerative Colitis. SAGE Publications, 2013.